HomeDMYD-B • STO
add
Diamyd Medical AB
Nakaraang pagsara
kr 9.21
Sakop ng araw
kr 9.34 - kr 10.50
Sakop ng taon
kr 7.50 - kr 25.00
Market cap
1.28B SEK
Average na Volume
349.64K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (SEK) | Peb 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 86.00K | 230.77% |
Gastos sa pagpapatakbo | 44.69M | 59.86% |
Net na kita | -44.87M | -53.39% |
Net profit margin | -52.17K | 53.63% |
Kita sa bawat share | — | — |
EBITDA | -44.01M | -60.78% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (SEK) | Peb 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 103.75M | -24.35% |
Kabuuang asset | 180.88M | -20.13% |
Kabuuang sagutin | 69.35M | 53.23% |
Kabuuang equity | 111.53M | — |
Natitirang share | 104.09M | — |
Presyo para makapag-book | 8.61 | — |
Return on assets | -56.58% | — |
Return on capital | -85.35% | — |
Cash Flow
Net change in cash
| (SEK) | Peb 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -44.87M | -53.39% |
Cash mula sa mga operasyon | -48.41M | -36.64% |
Cash mula sa pag-invest | -458.00K | 86.82% |
Cash mula sa financing | -635.00K | -203.83% |
Net change in cash | -49.13M | -24.15% |
Malayang cash flow | -32.72M | -9.70% |
Tungkol
Diamyd Medical AB is a small biotechnology company headquartered in Stockholm, Sweden that focuses on immune modifying therapies for diabetes. The company is developing two products.
The company is headquartered in Stockholm, and maintains a manufacturing facility in Umeå. Wikipedia
Itinatag
1984
Website
Mga Empleyado
30
